Cargando…
Clinical prediction model for tumor progression in Barrett’s esophagus
BACKGROUND: Individuals with Barrett’s esophagus (BE) are at increased risk of high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC), but the cost-effectiveness of general surveillance of BE is low. This study aimed to identify a risk prediction model for tumor progression in individuals wi...
Autores principales: | Holmberg, Dag, Ness-Jensen, Eivind, Mattsson, Fredrik, Lagergren, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684532/ https://www.ncbi.nlm.nih.gov/pubmed/30456503 http://dx.doi.org/10.1007/s00464-018-6590-5 |
Ejemplares similares
-
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
por: Holmberg, Dag, et al.
Publicado: (2022) -
Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study
por: Holmberg, Dag, et al.
Publicado: (2023) -
Cohort profile: the Swedish Prescribed Drugs and Health Cohort (SPREDH)
por: Xie, Shao-Hua, et al.
Publicado: (2019) -
Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014) -
Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma
por: Xie, Shao‐Hua, et al.
Publicado: (2020)